ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

lifetime health products pty ltd - propolis resin, quantity: 200 mg/ml (equivalent: lead, qty 2 microgram/ml) - liquid, multipurpose - excipient ingredients: propylene glycol - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; traditionally used in naturopathic medicine to soothe/relieve mouth/oral irritation ; traditionally used in naturopathic medicine to decrease/reduce/relieve symptoms of mild mouth ulcers ; maintain/support healthy immune system function ; traditionally used in naturopathic medicine to soothe/relieve skin inflammation ; traditionally used in naturopathic medicine to antimicrobial for minor cuts and abrasions ; traditionally used in naturopathic medicine to maintain/support wound healing

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - nitrous oxide, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - indications: 1. general anaesthesia: when an inhalation anaesthetic is required, the administration is usually accompanied by simultaneous administration of a volatile agent such as halothane, ethrane, etc. 2. analgesia with oxygen: - relief from severe pain, usually in emergency situations, by inhalation with oxygen. - useful also in short-term procedures which inevitably involve pain, such as wound and burn dressing, wound debridement and suturing. administration with oxygen. - in dental work to provide short-term analgesia for tooth extraction and other brief procedures. administration with oxygen. 3. others: - occasionally as an insufflating agent in laparoscopy. - in cryosurgery as a refrigerant.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

boc limited - nitrous oxide, quantity: 0.99 l/l - gas, medicinal - excipient ingredients: - indications as at 2 november 2001: nitrous oxide is indicated in adults and children for: 1. general anaesthesia, usually as an adjuvant to other volatile or intravenous anaesthetics. 2. analgesia (with oxygen) eg. dentistry and obstetrics.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - oxygen, quantity: 1 l/l - gas, medicinal - excipient ingredients: - .

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - oxygen, quantity: 1 l/l - gas, medicinal - excipient ingredients: - for respiratory delivery where there is a requirement for medicinal oxygen to treat or prevent hypoxemia.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 47487 - medical device electrical cable, general purpose - haemodynamic monitor connection cable.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 47487 - medical device electrical cable, general purpose - reusable electrical connection cables for the cmr system to allow for the transfer of energy from the generator to the monoplar and bipolar instruments

मलेशिया - अंग्रेज़ी - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

life biopharma sdn. bhd. - lincomycin hydrochloride (monohydrate); spectinomycin sulfate (tetrahydrate) -

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 12535 - medical equipment drape, single-use - a non-sterile protective barrier between the patient and the device intended to protect the lev? arm from fluids.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

swedish orphan biovitrum ab (publ) - palifermin (unii: qms40680k6) (palifermin - unii:qms40680k6) - palifermin 6.25 mg in 1.2 ml - kepivance is indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of autologous hematopoietic stem cell support. kepivance is indicated as supportive care for preparative regimens predicted to result in ≥ who grade 3 mucositis in the majority of patients. kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of autologous hematopoietic stem cell support. kepivance is indicated as supportive care for preparative regimens predicted to result in ≥ who grade 3 mucositis in the majority of patients. the safety and efficacy of kepivance have not been established in patients with non-hematologic malignancies )]. the safety and efficacy of kepivance have not been established in patients with non-hematologic malignancies